Author

Linda Vidman

Observed names: L. Vidman, Vidman, Linda

Institution: Umeå University

Observed institutions: Public Health Agency of Sweden, Umeå University

ORCID: 0000-0002-5012-4074

Observed ORCID: 0000-0002-5012-4074

OpenAlex ID: A5064771968

Emerging evidence of the role of gut microbiota in the development of allergic diseases

2016 · Kotryna Simonyte Sjödin, Linda Vidman, et al. · Current Opinion in Allergy and Clinical Immunology · 91

Epidemiology and Ecology of Tularemia in Sweden, 1984–2012

2014 · Amélie Desvars, Maria Furberg, et al. · Emerging infectious diseases · 66

PDF

Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts

2023 · Joseph A. Rothwell, Jelena Bešević, et al. · BMC Medicine · 48

PDF

Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition

2022 · Marie Breeur, Pietro Ferrari, et al. · BMC Medicine · 42

Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor

2019 · Elin Thysell, Linda Vidman, et al. · Molecular Oncology · 40

PDF

Cluster analysis on high dimensional RNA-seq data with applications to cancer research - An evaluation study

2019 · Linda Vidman, David Källberg, et al. · PLoS ONE · 37

PDF

A New Pipeline for the Normalization and Pooling of Metabolomics Data

2021 · Vivian Viallon, Mathilde His, et al. · Metabolites · 31

Untargeted plasma metabolomics and risk of colorectal cancer—an analysis nested within a large-scale prospective cohort

2023 · Linda Vidman, Rui Zheng, et al. · Cancer & Metabolism · 26

PDF

Comparison of Methods for Feature Selection in Clustering of High-Dimensional RNA-Sequencing Data to Identify Cancer Subtypes

2021 · David Källberg, Linda Vidman, et al. · Frontiers in Genetics · 25

PDF

Epidemiology and Ecology of Tularemia in Sweden.

2015 · A. Desvars, M. Furberg, et al. · International Journal of Epidemiology · 23

Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort

2021 · Mathilde His, Vivian Viallon, et al. · BMC Medicine · 18

PDF

Dietary patterns, untargeted metabolite profiles and their association with colorectal cancer risk

2024 · Stina Bodén, Rui Zheng, et al. · Scientific Reports · 8

PDF

Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma

2020 · Emma Andersson-Evelönn, Linda Vidman, et al. · Journal of Translational Medicine · 7

PDF

mRNA extracted from frozen buffy coat samples stored long term in tubes with no RNA preservative shows promise for downstream sequencing analyses

2025 · Erik Bovinder Ylitalo, Linda Vidman, et al. · PLoS ONE · 1

Abstract LB142: Metabolically defined body size phenotypes in relation to subsequent colorectal cancer risk

2023 · Linda Vidman, Simon Knekta, et al. · Cancer Research

Abstract 1332: Extracted mRNA from frozen buffy coat samples shows promise for use in downstream sequencing analyses

2023 · Erik Bovinder Ylitalo, Linda Vidman, et al. · Cancer Research

Additional file 1 of Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort

2021 · His, Mathilde, Viallon, Vivian, et al. · Figshare

Abstract 5475: Evaluation of feature selection methods used for cluster analysis in identification of novel cancer subtypes

2020 · Linda Vidman, David Källberg, et al. · Cancer Research

Combining epigenetic and clinicopathological variables improves prognostic prediction in clear cell Renal Cell Carcinoma

2020 · Emma Andersson-Evelönn, Linda Vidman, et al.

cancer subtype identification using cluster analysis on high-dimensional omics data

2020 · Linda Vidman · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Additional file 5 of Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma